1. Ackermann, D., Bidermann, C., Bailly, G., and Studer, U.E. (1988) Treatment of superficial bladder tumors with intravesical recombinant interferon alpha-2a. Urol. Int. 1 43: 85.
2. Atkins, M.B., Sparano, J., Fisher, R.I., Weiss, G.R., Margolin, K.A., et al. (1991) Randomized phase II trial of high dose IL-2 either alone or in combination with interferon alpha 2b (BFN) in advanced renal cell carcinoma (RCCA). Proc. Am. Soc. Clin. Oncol. (ASCO) (27th Ann. Mtg., May 19–21, 1991, Houston) 10: 166.
3. Atzpodien, J., Korfer, A., Menzel, T., Poliwoda, H. and Kirchner, H. Home therapy using recombinant human IL-2 and IFN-alpha-2b in patients with metastatic renal cell carcinoma. Proc. Am. Soc. Clin. Oncol. (ASCO) (27th Ann. Mtg., May 19–21, 1991, Houston) 10: 177, 1991
4. Avril, M.F., Beerblock, K., Dreno, B., Delaunay, M., Bonerandi, J.J., et al. (1990) Treatment of metastatic melanoma with a combination of dacarbazine and alpha-2A interferon: Results of a multicenter study. Bull. Cancer 77: 1183–1191.
5. Balch, CM., Shaw, H.M., Soong, S.J., et al. (1985) Changing trends in the clinical features of melanoma. In: Cutaneous Melanoma Clinical Management and Treatment Worldwide, Balch CM, Milton GW, eds. JB Lippincott, Philadelphia, pp 313.